Results 51 to 60 of about 1,555 (168)

[Clinical significance of multigene assay in papillary thyroid carcinoma]. [PDF]

open access: yesLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2023
Shi Y, Qian K, Guo K, Liu J, Wang Z.
europepmc   +1 more source

Mechanisms of drug resistance to targeted drugs in thyroid cancer [PDF]

open access: yes
For well-differentiated and early-stage thyroid cancer, conventional treatment options such as surgery, thyroid-stimulating hormone suppression therapy, and radioactive iodine therapy can usually significantly extend patients’ overall survival and ...
WEN Xinyun, WU Juekun
core   +1 more source

BRAFV600E突变与甲状腺乳头状癌临床病理特征关系的研究进展

open access: yesZhongguo shiyan zhenduanxue
甲状腺癌是内分泌系统最常见的恶性肿瘤,近年来发病率逐年上升。根据国家癌症中心数据显示,甲状腺癌发病率已居于恶性肿瘤发病率的第7位[1]。甲状腺癌主要包括乳头状癌、滤泡状癌、髓样癌及未分化癌4种类型,其中,甲状腺乳头状癌(papillary thyroid carcinoma, PTC)的发生率在甲状腺癌的病理类型中居于首位。在众多甲状腺癌相关的基因中,BRAF基因突变是甲状腺乳头状癌最常见的突变位点,BRAFV600E突变率在甲状腺微小乳头状癌(papillary thyroid ...
吴宪吉   +5 more
doaj  

术前超声评估影响甲状腺乳头状癌复发率的相关性研究

open access: yesZhongguo shiyan zhenduanxue, 2023
甲状腺癌的发病率在世界范围内持续上升,而甲状腺乳头状癌(PTC)占所有甲状腺癌的绝大多数(85%),虽然 PTC 通常具有良好的预后,10年疾病特异性生存率超过 90%,对于大约 30% 的患者来说,复发仍然是一个问题[1]。因此,识别与预后不良相关的因素仍然是指导PTC患者治疗和监测的高度优先事项。2009年,ATA采用了一种新系统,可识别高、中、低复发风险。该系统是单独甲状腺切除术或放射性碘残余消融治疗分化型甲状腺癌的可靠预测因子。
冯庆, 李秀昆, 贾杰, 王辉
doaj  

Effect of platelet-derived growth factor on the activity and invasion ability of choroidal melanoma cells [PDF]

open access: yes
Objective To investigate the effect of platelet-derived growth factor (PDGF) on the activity and invasion ability of choroidal melanoma (CM) cells.
YAO Ningning, YUAN Yingying, MA Qingyue, YI Wendan, SUI Aihua, LUO Wenjuan
core   +1 more source

Shh在甲状腺乳头状癌中的表达及其临床意义研究

open access: yesZhongguo shiyan zhenduanxue, 2011
甲状腺癌是最常见的内分泌系统的恶性肿癌(>90%)。近期的流行病学调查显示,其发病率呈上升趋势[1]。甲状腺乳头状癌(Papillary thyroid Carcinoma,PTC)是甲状腺癌最常见的病理类型 ...
边学海   +6 more
doaj  

颈淋巴结清扫术在CN0期甲状腺乳头状癌中的应用价值

open access: yesZhongguo shiyan zhenduanxue, 2016
目的探讨颈淋巴结清扫术在CN0期甲状腺乳头状癌中的应用价值。方法回顾性分析2012年2月至2014年2月在吉林大学第一医院接受首次手术治疗并经病理证实的121例CN0期甲状腺乳头状癌患者的临床与病理资料。结果 1121例CN0期甲状腺乳头状癌患者的颈淋巴结转移率为45.45%(55/121),其中以Ⅵ区淋巴结转移率最高,约为43.80%(53/121),侧颈区(Ⅱ、Ⅲ、Ⅳ区)淋巴结转移率为13.22%(16/121)。2Ⅵ区与侧颈区淋巴结转移率比较,差异有统计学意义 ...
逄仁柱, 孟宪瑛, 童岚, 李群
doaj  

[Curcumin suppresses proliferation, migration and invasion of papillary thyriod cancer B-CPAP cells through the Keap1-Nrf2 pathway]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2023
Ren L   +7 more
europepmc   +1 more source

Diagnosis of Primary Acinic Cell Carcinoma of the Lung Using CT: A Case Analysis [PDF]

open access: yes
Acinic cell carcinoma (ACC) is a malignant epithelial salivary gland neoplasm that most frequently occurs in the salivary glands. However, primary ACC of the lung is extremely rare.
Di PENG   +4 more
core   +1 more source

99mTc-MIBI双时相显像诊断原发性异位甲状旁腺亢进性腺瘤伴对侧甲状腺微小乳头状癌1例

open access: yesZhongguo shiyan zhenduanxue, 2016
原发性异位甲状旁腺功能亢进性腺瘤临床少见,而同时伴发甲状腺乳头状癌者更为罕见,本文现报道1例经99mTc-MIBI双时相甲状旁腺显像诊断原发性异位甲状旁腺功能亢进性腺瘤同时伴有对侧甲状腺微小乳头状癌患者。1一般资料患者,女,47岁,因"发现甲状腺肿物2年"。于2015-10-28入吉大二院甲状腺外科,病程中患者一般状态尚可,无疼痛、无吞咽困难,无饮水呛咳及声音嘶哑,无呼吸困难,无发热、多汗,无心悸、心慌 ...
赵银龙   +4 more
doaj  

Home - About - Disclaimer - Privacy